1. Home
  2. Live Updates
  3. American society of clinical oncology annual meeting

Live Breaking News & Updates on American society of clinical oncology annual meeting

Stay informed with the latest breaking news from American society of clinical oncology annual meeting on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in American society of clinical oncology annual meeting and stay connected to the pulse of your community

Latest Novartis Kisqali® NATALEE analysis reinforces 25% reduction in risk of recurrence across broad population of patients with early breast cancer; supports regulatory submissions

With 5.6 months of additional follow-up and 78.3% of patients having completed Kisqali® (ribociclib) investigational treatment, the updated analysis shows...

San-antonio , Texas , United-states , Barcelona , Comunidad-autonoma-de-cataluna , Spain , France , Switzerland , Paris , France-general- , Chicago , Illinois

Novel Drug Combo Fast Tracked for Advanced Breast Cancer Subset

Zotatifin plus Faslodex and Verzenio was granted as a Fast Track Designation for the treatment of ER-positive, HER2-negative advanced or metastatic breast cancer.

United-states , San-antonio , Texas , American , Steve-worland , American-society-of-clinical-oncology-annual-meeting , Drug-administration , Fast-track-designation , Track-designations , Fast-track , Clinical-oncology-annual-meeting , San-antonio-breast-cancer-symposium

Mural Oncology spins out from Alkermes with $275M, lead immunotherapy program

The spinoff between Mural and Alkermes created two pure-play companies.

United-states , American , Marc-goodman , Glympse-bio , American-society-of-clinical-oncology-annual-meeting , Alkermes , Bristol-myers-squibb , Nasdaq , Mural-oncology , Caroline-loew , Bristol-myers , American-society

eFFECTOR Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update

13.11.2023 - Management intends to provide an update on its zotatifin clinical development program in estrogen receptor-positive (ER+) metastatic breast cancer (mBC) at the 2023 San Antonio Breast Cancer Symposium (SABCS) Topline results from Phase 2b KICKSTART ...

Russia , United-states , Ukraine , American , Kevin-gardner , Jennifer-caswell-jin , Christian-curtis , Steve-worland , Christopherm-calabrese , Mike-tattory , Development-rd-expenses , Roberth-lurie-comprehensive-cancer-center

Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q3 2023 Earnings Call Transcript

Operator: Hello, and thank you for standing by. Welcome to the Allogene Therapeutics Third Quarter 2023 Conference Call.

United-states , Canada , Australia , American , Michael-yee , Tyler-van-baron , Christine-cassiano , Brian-cheng , Zachary-roberts , Jack-allen , Marcelo-pasquini , David-chang

Merck - KEYTRUDA Significantly Improved Overall Survival versus Placebo as Adjuvant Therapy for Certain Patients with Renal Cell Carcinoma Following Nephrectomy

RAHWAY - Merck , known as MSD outside of the United States and Canada, today announced that the Phase 3 KEYNOTE-564 trial evaluating KEYTRUDA, Merck's anti-PD-1 therapy, met its key secondary...

Japan , United-states , Canada , American , Julie-cunningham , Peter-dannenbaum , Michael-mcardle , European-society-for-medical-oncology , Exchange-commission , European-union , Data-monitoring-committee , American-society-of-clinical-oncology-annual-meeting

KEYTRUDA® (pembrolizumab) Significantly Improved Overall Survival (OS) Versus Placebo as Adjuvant Therapy for Certain Patients With Renal Cell Carcinoma (RCC) Following Nephrectomy

KEYTRUDA® (pembrolizumab) Significantly Improved Overall Survival (OS) Versus Placebo as Adjuvant Therapy for Certain Patients With Renal Cell Carcinoma (RCC) Following Nephrectomy
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Japan , United-states , Canada , American , Peter-dannenbaum , Michael-mcardle , Julie-cunningham , Damini-chokshi , Youtube , Instagram , Statement-of-merck-co-inc , Merck-research-laboratories

SpringWorks Therapeutics Announces Presentation of Additional Data from Phase 3 DeFi Trial of Nirogacestat in Adults with Desmoid Tumors at the 2023 CTOS Annual Meeting

SpringWorks Therapeutics Announces Presentation of Additional Data from Phase 3 DeFi Trial of Nirogacestat in Adults with Desmoid Tumors at the 2023 CTOS Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Germany , United-states , Heidelberg , Baden-wüberg , France , Chicago , Illinois , Mannheim , Denmark , Coindre , Auvergne , Anneberg

KEYTRUDA® (pembrolizumab) Significantly Improved Overall Survival (OS) Versus Placebo as Adjuvant Th

KEYTRUDA is the first therapy to show a statistically significant improvement in OS as adjuvant therapy in patients with RCC at a higher risk of recurrence following nephrectomyNew OS results build on the significant disease-free survival benefit previously reported from the KEYNOTE-564 trialRAHWAY, N.J.--(BUSINESS...

Japan , Canada , United-states , American , Peter-dannenbaum , Julie-cunningham , Michael-mcardle , Damini-chokshi , Merck-research-laboratories , American-society-of-clinical-oncology-annual-meeting , Data-monitoring-committee , European-society-for-medical-oncology

Immunogen (IMGN) Announces EU Acceptance of Marketing Authorization Application for Mirvetuximab Soravtansine

Immunogen (IMGN) Announces EU Acceptance of Marketing Authorization Application for Mirvetuximab Soravtansine
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , American , Michael-vasconcelles , Nasdaq , European-medicines-agency , Immunogen-inc , American-society-of-clinical-oncology-annual-meeting , Marketing-authorization-application , Executive-vice-president , Clinical-oncology-annual , Drug-administration ,